|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1966-01-18 |
A Randomised, Placebo Controlled Trial of Azithromycin for the Prevention of Chronic Lung Disease of Prematurity in Preterm Infants
The aim of the TINN2 study is to evaluate the efficacy of azithromycin in prevention of bronchopulmonary dysplasia in preterm neonates.
NEMO1: An Open Label Exploratory Dose Finding and Pharmacokinetic Clinical Trial of Bumetanide for the Treatment of Neonatal Seizure Using Medication Off-patent
NEMO is a multicentre pan European clinical trial with the aim to develop new treatment strategies for the treatment of neonatal seizures using the loop diuretic bumetanide. There is evidence that bumetanide improves GABAergic function of the current standard drug, phenobarbitone. Bumetanide has been used as a diuretic in term and preterm babies for around thirty years. This trial should confirm that Bumetanide in addition to standard treatment will result in better seizures control.
NEMO-1:An open label exploratory dose finding and pharmacokinetic clinical trial of bumetanide for the treatment of NEonatal seizure using Medication Off-patent. - NEMO1
100 项与 Only For Children Pharmaceuticals SA 相关的临床结果
0 项与 Only For Children Pharmaceuticals SA 相关的专利(医药)
100 项与 Only For Children Pharmaceuticals SA 相关的药物交易
100 项与 Only For Children Pharmaceuticals SA 相关的转化医学